Lucia Carulli

Modena, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19.

Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19.

Journal: Blood advances
Published: November 02, 2020

Retraction: Carulli, L. et al. The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD). Metabolites 2019, 9(2), 25.

Retraction: Carulli, L. et al. The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD). Metabolites 2019, 9(2), 25.

Journal: Metabolites
Published: April 09, 2019

The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD).

The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD).

Journal: Metabolites
Published: December 31, 2018

Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma.

Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma.

Journal: Hepatology (Baltimore, Md.)
Published: August 30, 2018

Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study.

Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study.

Journal: Drugs & aging
Published: March 17, 2017

Telomere length elongation after weight loss intervention in obese adults.

Telomere length elongation after weight loss intervention in obese adults.

Journal: Molecular genetics and metabolism
Published: February 12, 2016

Bile acids and nonalcoholic fatty liver disease: An intriguing relationship.

Bile acids and nonalcoholic fatty liver disease: An intriguing relationship.

Journal: Hepatology (Baltimore, Md.)
Published: July 01, 2015

Telomere shortening as genetic risk factor of liver cirrhosis.

Telomere shortening as genetic risk factor of liver cirrhosis.

Journal: World journal of gastroenterology
Published: October 08, 2014

WITHDRAWN: Telomeres and atherosclerosis.

WITHDRAWN: Telomeres and atherosclerosis.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: May 05, 2014

Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population.

Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population.

Journal: Clinical interventions in aging
Published: March 27, 2014

Telomere and telomerase in chronic liver disease and hepatocarcinoma.

Telomere and telomerase in chronic liver disease and hepatocarcinoma.

Journal: World journal of gastroenterology
Published: January 04, 2014

In vivo degradation of cholesterol to bile acids is reduced in patients receiving parenteral nutrition.

In vivo degradation of cholesterol to bile acids is reduced in patients receiving parenteral nutrition.

Journal: JPEN. Journal of parenteral and enteral nutrition
Published: February 22, 2013
Showing 1-12 of 18

Last Updated: 09/26/2026